Associate Medical Director/Medical Director - Rheumatology/Dermatology
Thermo Fisher ScientificSalary not specified
Director, MEG Lead Hematology, Medical Evidence Generation at Bristol-Myers Squibb
Princeton, New Jersey, United States
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries
Requirements
- Advanced scientific degree (MD, PhD, or PharmD or the equivalent) required with extensive, relevant scientific, and/or clinical experience
- At least 7 years of experience in pharmaceutical clinical development, Medical Affairs or relevant Commercial experience; previous customer-facing role experience highly desirable
- Demonstrated ability to strategically analyze data generation opportunities with minimal supervision
- Demonstrated ability to develop and sustain high-performing relationships with external thought leaders and internal matrix stakeholders
- Adeptness at building credibility with external investigators and collaborative partners competently balancing business and scientific acumen complemented by strong leadership behaviors, authenticity, agility, and an enterprise mindset
- Understanding of global healthcare systems and academic settings with a demonstrated ability to lead in ambiguous and changing healthcare/business environments
- Exceptional communication and interpersonal skills to influence decision-making at all levels of the organization
- In depth knowledge of overall project planning and project management of clinical trials
- Proven ability to partner effectively with colleagues across multiple functions and at all levels of the enterprise
Responsibilities
- Facilitate collaborative exchange between BMS and thought leaders in community practice and academia, including scientific dialogue and representing BMS as a trusted, inclusive, and innovative industry collaborator and partner of choice
- Be accountable for delivering CRCs, ISRs, and MASTs from concept ideation to governance approval and throughout the study lifecycle
- Act as point of contact for CRCs, ISRs, and MASTs within Therapeutic and Disease area teams
- Design and drive strategies to accelerate the development of BMS’s clinical development pipeline leveraging external research platforms, technologies, and insights
- Align with and advise senior functional and therapeutic area leaders on new external opportunities that will inform strategy and influence decisions in the creation/refinement of integrated evidence generation plans
- Personally lead a limited number of high-visibility projects leveraging relevant disease subject matter expertise
- Contribute to the evolution of MEG therapeutic area strategy and value proposition
Skills
Key technologies and capabilities for this role
Questions & Answers
Common questions about this position
What qualifications are required for the Director, MEG Lead Hematology role?
An advanced scientific degree such as MD, PhD, or PharmD (or equivalent) is required, along with at least 7 years of experience in pharmaceutical clinical development, Medical Affairs, or relevant Commercial experience, and extensive relevant scientific and/or clinical experience.
Is this position remote or does it require working from an office?
The position is based at the Lawrenceville (PPK) or Madison (GIR) site in New Jersey.
What is the salary for this role?
This information is not specified in the job description.
What is the company culture like at Bristol Myers Squibb?
BMS offers a challenging, meaningful, and life-changing work environment with uniquely interesting work every day, opportunities to grow and thrive alongside high-achieving teams, and a focus on balance and flexibility.
What experience makes a strong candidate for this position?
Candidates with an advanced scientific degree, at least 7 years in pharmaceutical clinical development, Medical Affairs, or Commercial roles, previous customer-facing experience, and expertise in hematology or evidence generation will stand out.
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees
